Antihemophilic Factor (Recombinant), PEGylated

Antihemophilic Factor (Recombinant), PEGylated may be found in some form under the following brand names:

• Adynovate

Antihemophilic Factor (Recombinant), PEGylated is part of the drug class:

• Blood coagulation factors

No drug interactions have been studied by the manufacturer. However, you should tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Not all drug interactions are known or reported and new drug interactions are continually being reported.

Tell your doctor if you are breastfeeding or plan to breastfeed.

It is not known if Antihemophilic Factor (Recombinant), PEGylated crosses into human milk. Because many medications can cross into human milk and because of the possibility for serious adverse reactions in nursing infants with use of this medication, a choice should be made whether to stop nursing or stop the use of this medication. Your doctor and you will decide if the benefits outweigh the risk of using Antihemophilic Factor (Recombinant), PEGylated.

This medication comes as a dry powder to be mixed into a solution and injected into a vein (IV) by a healthcare provider. Many people with hemophilia A learn to infuse their Antihemophilic Factor (Recombinant), PEGylated by themselves or with the help of a family member.

Do not attempt to do an infusion to yourself unless you have been taught how by your healthcare provider or hemophilia center.

You must carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Antihemophilic Factor (Recombinant), PEGylated so that your treatment will work best for you.

You may have to have blood tests done after receiving Antihemophilic Factor (Recombinant), PEGylated to be sure that your blood level of factor VIII is high enough to clot your blood.

Call your healthcare provider right away if your bleeding does not stop after taking Antihemophilic Factor (Recombinant), PEGylated.

If you take too much Antihemophilic Factor (Recombinant), PEGylated, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

If Antihemophilic Factor (Recombinant), PEGylated is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.